Screener
Bioventus BVS Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Bioventus’s reported figures.
Based on trailing twelve months.
The source filing: Bioventus’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
FAQ
- What is Bioventus's return on equity?
- Bioventus (BVS) reported return on equity of 28% in Q2 2026.
- How has Bioventus's return on equity changed year-over-year?
- Bioventus's return on equity increased by 6071.1% year-over-year, from -0.5% to 28%.
- What is the long-term trend for Bioventus's return on equity?
- Over 3 years (2022 to 2025), Bioventus's return on equity has grown at a -30.3% compound annual growth rate (CAGR), from -40.5% to 13.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Bioventus's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude